journal
https://read.qxmd.com/read/38213160/exploring-the-efficient-natural-products-for-the-therapy-of-parkinson-s-disease-via-drosophila-melanogaster-fruit-fly-models
#21
JOURNAL ARTICLE
Wen Zhang, Yingjie Ju, Yunuo Ren, Yaodong Miao, Yiwen Wang
Parkinson's disease (PD) is a severe neurodegenerative disorder, partly attributed to mutations, environmental toxins, oxidative stress, abnormal protein aggregation, and mitochondrial dysfunction. However, the precise pathogenesis of PD and its treatment strategy still require investigation. Fortunately, natural products have demonstrated potential as therapeutic agents for alleviating PD symptoms due to their neuroprotective properties. To identify promising lead compounds from herbal medicines' natural products for PD management and understand their modes of action, suitable animal models are necessary...
January 10, 2024: Current Drug Targets
https://read.qxmd.com/read/38192136/bile-acid-application-in-cell-targeting-for-molecular-receptors-in-relation-to-hearing-a-comprehensive-review
#22
JOURNAL ARTICLE
Corina M Ionescu, Melissa A Jones, Susbin R Wagle, Bozica Kovacevic, Thomas Foste, Momir Mikov, Armin Mooranian, Hani Al-Salami
Bile acids play important roles in the human body, and changes in their pool can be used as markers for various liver pathologies. In addition to their functional effects in modulating inflammatory responses and cellular survivability, the unconjugated or conjugated, secondary, or primary nature of bile acids accounts for their various ligand effects. The common hydrophilic bile acids have been used successfully as local treatment to resolve drug-induced cell damage or to ameliorate hearing loss. From various literature references, bile acids show concentration and tissue-dependent effects...
January 8, 2024: Current Drug Targets
https://read.qxmd.com/read/38444255/transcription-factors-in-brain-regeneration-a-potential-novel-therapeutic-target
#23
JOURNAL ARTICLE
Basheer Abdullah Marzoog
Transcription factors play a crucial role in providing identity to each cell population. To maintain cell identity, it is essential to balance the expression of activator and inhibitor transcription factors. Cell plasticity and reprogramming offer great potential for future therapeutic applications, as they can regenerate damaged tissue. Specific niche factors can modify gene expression and differentiate or transdifferentiate the target cell to the required fate. Ongoing research is being carried out on the possibilities of transcription factors in regenerating neurons, with neural stem cells (NSCs) being considered the preferred cells for generating new neurons due to their epigenomic and transcriptome memory...
2024: Current Drug Targets
https://read.qxmd.com/read/38155465/rho-kinase-rock-inhibitors-for-the-treatment-of-glaucoma
#24
JOURNAL ARTICLE
Junhui Wu, Jing Wei, Haoliang Chen, Yalong Dang, Fang Lei
Glaucoma is the most common cause of irreversible blindness worldwide. It is characterized by progressive optic nerve degeneration and loss of visual field. Pathological increased intraocular pressure is its main modifiable risk factor. Rho kinase inhibitors are developed as a new class of glaucoma medication that increases outflow facility from the conventional aqueous humor outflow pathway. Additionally, they also have neuropective and anti-scarring effects that can might increase the success rate of glaucoma filtration surgery...
December 28, 2023: Current Drug Targets
https://read.qxmd.com/read/38151842/breaking-barriers-current-advances-and-future-directions-in-mpox-therapy
#25
JOURNAL ARTICLE
Bhumi M Shah, Palmi Modi
BACKGROUND: Mpox, a newly discovered zoonotic infection, can be transmitted from animal to human and between humans. Serological and genomic studies are used to identify the virus. OBJECTIVE: Currently, there are no proven effective treatments for Mpox. Also, the safety and efficacy of intravenous vaccinia immune globulin, oral Tecovirimat (an inhibitor of intracellular viral release), and oral Brincidofovir (a DNA polymerase inhibitor) against the Mpox virus are uncertain, highlighting the need for more effective and safe treatments...
December 27, 2023: Current Drug Targets
https://read.qxmd.com/read/38151841/clpp-peptidase-as-a-plausible-target-for-the-discovery-of-novel-antibiotics
#26
JOURNAL ARTICLE
Smriti Bhardwaj, Kuldeep K Roy
Antimicrobial resistance (AMR) to currently available antibiotics/drugs is a global threat. It is desirable to develop new drugs that work through a novel target(s) to avoid drug resistance. This review discusses the potential of the caseinolytic protease P (ClpP) peptidase complex as a novel target for finding novel antibiotics, emphasising the ClpP's structure and function. ClpP contributes to the survival of bacteria via its ability to destroy misfolded or aggregated proteins. In consequence, its inhibition may lead to microbial death...
December 27, 2023: Current Drug Targets
https://read.qxmd.com/read/38141198/does-the-grape-products-intake-has-an-effect-on-body-weight-in-adults-a-systematic-review-and-meta-analysis-of-randomized-controlled-trials
#27
JOURNAL ARTICLE
Mohammad Ali Goudarzi, Zahra Sohrabi, Mohammad Hashem Hashempur, Saeed Nosratabadi, Zahra Namkhah, Cain C T Clark, Neda Haghighat
INTRODUCTION: There is a growing interest in the considerable benefits of grape products intake, as some studies have indicated that they may improve cardiometabolic risk factors. However, the widespread impact of grape products on the anthropometric indices is not fully resolved. METHOD: The purpose of this systematic review and meta-analysis was to examine the effects of grape products intake on anthropometric indices in adults. Randomized controlled trials (RCT) examining the effects of grape products intake on anthropometric indices, published up to December 2021, were identified through PubMed, SCOPUS, and ISI Web of Science databases...
December 21, 2023: Current Drug Targets
https://read.qxmd.com/read/38115619/tebentafusp-as-a-promising-drug-for-the-treatment-of-uveal-melanoma
#28
JOURNAL ARTICLE
Khalid Al Balushi, Abdulrahman Al Hadhrami, Hamdan Al Balushi, Srijit Das, Abdullah Al Lawati
Uveal melanoma (UM) is the most common primary intraocular malignancy in adults and commonly occurs in the Caucasian population. The malignancy involves the uvea of the eye, which includes the iris, ciliary body, and choroid. The etiology of UM is still not well understood, but age is a risk factor. Symptoms include blurred vision, redness of the eye, floaters, dark spots, a change in the size of the pupil, and loss of vision. The location, shape, and size of the tumor are important for therapeutic purposes...
December 19, 2023: Current Drug Targets
https://read.qxmd.com/read/38115618/an-exploratory-review-on-the-hypoglycemic-action-of-unani-anti-diabetic-drugs-via-possible-modulation-of-gut-microbiota
#29
JOURNAL ARTICLE
Shaheen Akhlaq, Shabnam Anjum Ara, Malik Itrat, Mohammad Fazil, Bilal Ahmad, Usama Akram, Merajul Haque, Neelam Quddusi, Ahmad Sayeed
BACKGROUND AND AIM: Diabetes mellitus is a chronic, multi-factorial metabolic disorder and also an important public health issue that requires multi-dimensional therapeutic strategies for effective control. Unani herbs have long been used to effectively mitigate diabetes through various mechanisms. In recent years, it has been speculated that the alteration of gut microbiome ecology is potentially one of the important mechanisms through which the Unani drugs exert hypoglycemic action...
December 19, 2023: Current Drug Targets
https://read.qxmd.com/read/38083893/an-update-on-the-emerging-role-of-wnt-%C3%AE-catenin-syk-pi3k-akt-and-gm-csf-signaling-pathways-in-rheumatoid-arthritis
#30
JOURNAL ARTICLE
Pradyuman Prajapati, Gaurav Doshi
Rheumatoid arthritis is an untreatable autoimmune disorder. The disease is accompanied by joint impairment and anomalies, which negatively affect the patient's quality of life and contribute to a decline in manpower. To diagnose and treat rheumatoid arthritis, it is crucial to understand the abnormal signaling pathways that contribute to the disease. This understanding will help develop new rheumatoid arthritis-related intervention targets. Over the last few decades, researchers have given more attention to rheumatoid arthritis...
December 11, 2023: Current Drug Targets
https://read.qxmd.com/read/38058096/recent-progress-and-challenges-in-clinical-translation-of-nanomedicines-in-diagnosis-and-treatment-of-lung-cancer
#31
JOURNAL ARTICLE
Bhavna Yadav, Mahima Chauhan, Rahul Pratap Singh, Sonali, Saurabh Shekhar
Lung cancer is one of the leading causes of death across the world. There are numerous challenges in the early diagnosis and effective treatment of lung cancer, including developing multidrug resistance. However, the diagnosis of lung cancer could be minimally invasive or non-invasive. Nowadays, nanomedicines offer solutions to several emerging challenges in drug delivery research areas. It has the potential to enhance the therapeutic efficacy of biologically and chemically active agents at the site of action...
December 6, 2023: Current Drug Targets
https://read.qxmd.com/read/38053356/an-outbreak-of-eye-flu-virus-in-india
#32
JOURNAL ARTICLE
Raj Kamal, Debanjan Mukherjee, Amandeep Singh
No abstract text is available yet for this article.
December 5, 2023: Current Drug Targets
https://read.qxmd.com/read/38053355/therapeutic-potential-of-targeting-transforming-growth-factor-beta-tgf-%C3%AE-and-programmed-death-ligand-1-pd-l1-in-pancreatic-cancer
#33
JOURNAL ARTICLE
Ghazaleh Pourali, Nima Zafari, Mahla Velayati, Shima Mehrabadi, Mina Maftooh, Seyed Mahdi Hassanian, Majid Ghayour-Mobarhan, Gordon A Ferns, Amir Avan, Majid Khazaei
Pancreatic cancer (PC) is one the most lethal malignancies worldwide affecting around half a million individuals each year. The treatment of PC is relatively difficult due to the difficulty in making an early diagnosis. Transforming growth factor-beta (TGF-β) is a multifunctional factor acting as both a tumor promoter in early cancer stages and a tumor suppressor in advanced disease. Programmed death-ligand 1 (PD-L1) is a ligand of programmed death-1 (PD-1), an immune checkpoint receptor, allowing tumor cells to avoid elimination by immune cells...
December 5, 2023: Current Drug Targets
https://read.qxmd.com/read/38037998/deciphering-the-function-of-new-therapeutic-targets-and-prospective-biomarkers-in-the-management-of-psoriasis
#34
JOURNAL ARTICLE
Japneet Singh Purewal, Gaurav Mahesh Doshi
Psoriasis is an immune-mediated skin condition affecting people worldwide, presenting at any age, and leading to a substantial burden physically and mentally. The innate and adaptive immune systems interact intricately with the pathomechanisms that underlie disease. T cells can interact with keratinocytes, macrophages, and dendritic cells through the cytokines they secrete. According to recent research, psoriasis flare-ups can cause systemic inflammation and various other co-morbidities, including depression, psoriatic arthritis, and cardio-metabolic syndrome...
November 30, 2023: Current Drug Targets
https://read.qxmd.com/read/38037997/biological-potential-and-therapeutic-effectiveness-of-geiparvarin-in-medicine-for-its-anti-proliferative-activity-against-tumors-and-other-human-complications
#35
EDITORIAL
Dinesh Kumar Patel
No abstract text is available yet for this article.
November 30, 2023: Current Drug Targets
https://read.qxmd.com/read/38037996/the-development-of-the-combination-drug-leukovir%C3%A2-tablets-for-the-treatment-of-multiple-sclerosis-a-comprehensive-review
#36
JOURNAL ARTICLE
Elena Kalinichenko, Svetlana Babitskaya
The review is devoted to the development and study of the drug Leukovir® (cladribine+ ribavirin) and its use in the treatment of relapsing-remitting and secondary progressive forms of multiple sclerosis, a chronic neurodegenerative disease aiming the risk reduction of relapse and progression of a disability. In clinical trials Leukovir® has proved to be efficient by up to 56 weeks for the treatment of relapsing-remitting and secondary progressive forms of multiple sclerosis. The drug is registered in the Republic of Belarus...
November 30, 2023: Current Drug Targets
https://read.qxmd.com/read/38037995/novel-targets-and-drug-delivery-system-in-the-treatment-of-postoperative-pain-recent-studies-and-clinical-advancement
#37
JOURNAL ARTICLE
Trilochan Satapathy, Gulab Singh, Ravindra Kumar Pandey, Shiv Shankar Shukla, Shiv Kumar Bhardwaj, Beena Gidwani
Pain is generated by a small number of peripheral targets. These can be made more sensitive by inflammatory mediators. The number of opioids prescribed to the patients can be reduced dramatically with better pain management. Any therapy that safely and reliably provides extended analgesia and is flexible enough to facilitate a diverse array of release profiles would be useful for improving patient comfort, quality of care, and compliance after surgical procedures. Comparisons are made between new and traditional methods, and the current state of development has been discussed; taking into account the availability of molecular and cellular level data, preclinical and clinical data, and early post-market data...
November 30, 2023: Current Drug Targets
https://read.qxmd.com/read/38037994/flavonoids-as-g-protein-coupled-receptors-ligands-new-potential-therapeutic-natural-drugs
#38
JOURNAL ARTICLE
Rachid Bencheikh, Alae Chda
G protein coupled receptors (GPCRs) are among the largest family of cell surface re-ceptors found in the human genome. They govern a wide range of physiological responses in both health and diseases, making them one of the potential targeted surface receptors for pharmaceuti-cals. Flavonoids can modulate GPCRs activity by acting as allosteric ligands. They can either en-hance or reduce the GPCR's effect. Emerging research shows that individual flavonoids or mix-tures of flavonoids from plant extract can have relevant pharmacological effects against a number of diseases including GPCRs...
November 30, 2023: Current Drug Targets
https://read.qxmd.com/read/38037908/antiviral-potential-of-traditional-unani-medicine-in-viral-diseases-with-special-emphasis-on-dengue-a-review
#39
JOURNAL ARTICLE
Muzayyana Khan, Mohammad Altamish, Monalisha Samal, Varsha Srivastava, Areeba Insaf, Rabea Parveen, Jamal Akhtar, Anuja Krishnan, Sayeed Ahmad
Dengue fever has become a major public health concern. It is usually related to intravascular leaking, bleeding disorders, and thrombocytopenia and is recognized as a potent threat to humans. The scarcity of anti-dengue medication or vaccine for such a serious disease leads to an upsurge in the usage of traditional medicines for its proper management. India has diverse biodiversity and a long history of using plant-based remedies. Several medicinal plant extracts have been studied for producing anti-dengue viral activity...
November 21, 2023: Current Drug Targets
https://read.qxmd.com/read/37953621/targeted-delivery-strategies-of-herbal-based-nanogels-advancements-and-applications
#40
JOURNAL ARTICLE
Sudhanshu Mishra, Sonali Jayronia, Lalit Kumar Tyagi, Kanchan Kohli
The objective of this review is to thoroughly investigate herbal nano gels as a promising drug delivery approach for the management of various chronic and acute disorders. Herbal nano gels are a novel and promising drug delivery technique, offering special benefits for better therapeutic efficacy. This review offers a comprehensive analysis of the herbal nano gels with a particular emphasis on their evaluation concerning conventional dosage forms, polymer selection criteria, drug release mechanisms, and applications...
November 10, 2023: Current Drug Targets
journal
journal
35111
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.